Prospective study on clinical and immunological Aspergillus categorization in cystic fibrosis.

S. Kaufmann (Berlin, Germany), J. Röhmel (Berlin, Germany), P. Eschenhagen (Berlin, Germany), A. Mehl (Berlin, Germany), C. Meinus (Berlin, Germany), D. Staab (Berlin, Germany), V. Rickerts (Berlin, Germany), K. Seidel (Berlin, Germany), P. Bacher (Berlin, Germany), A. Scheffold (Berlin, Germany), C. Schwarz (Berlin, Germany)

Source: International Congress 2018 – Cystic fibrosis in adults: current research
Session: Cystic fibrosis in adults: current research
Session type: Thematic Poster
Number: 1329
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Kaufmann (Berlin, Germany), J. Röhmel (Berlin, Germany), P. Eschenhagen (Berlin, Germany), A. Mehl (Berlin, Germany), C. Meinus (Berlin, Germany), D. Staab (Berlin, Germany), V. Rickerts (Berlin, Germany), K. Seidel (Berlin, Germany), P. Bacher (Berlin, Germany), A. Scheffold (Berlin, Germany), C. Schwarz (Berlin, Germany). Prospective study on clinical and immunological Aspergillus categorization in cystic fibrosis.. 1329

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Aspergillus pulmonary disease in cystic fibrosis (CF) patients: multicentre perspective observational study based on new diagnostic tests to evaluate the prognostic value on the CF disease
Source: Virtual Congress 2021 – Adult cystic fibrosis
Year: 2021



Clinical validity of functional respiratory imaging in cystic fibrosis: a cross-sectional study.
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021


End-points and biomarkers for clinical trials in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 104-115
Year: 2014


Prospective evaluation of cardio-metabolic comorbidities in a cohort of patients with non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020


Enzymatic activity and clinical parameters in non-cystic fibrosis bronchiectasis: A cohort analysis
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012

A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Prospective case-control study describing the lower airway microbiome in pre-school children with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018



Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Prospective longitudinal evaluation of physical activities and pulmonary and nutritional status in children with cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 618s
Year: 2004

Do patients with cystic fibrosis participating in clinical trials demonstrate placebo response ? A meta-analysis.
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Bacterial colonisation in children with non-cystic fibrosis bronchiectasis: a retrospective longitudinal study
Source: International Congress 2017 – Paediatric bronchology in clinical practice
Year: 2017


A retrospective observational study: Bidirectional pharmacokinetic interactions between ivacaftor-lumacaftor in cystic fibrosis
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020


Clinical, functional and radiologic progression in Interstitial pneumonia with autoimmune features (IPAF): a prospective cohort-study
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016

The concept of cystic fibrosis pulmonary exacerbation in clinical medicine and as a trial end-point
Source: Annual Congress 2008 - Exacerbations of chronic respiratory disease – state of the art
Year: 2008


Assessment of NuvoAir platform use on clinical outcomes in adults with cystic fibrosis: a first Italian experience
Source: Virtual Congress 2021 – Cystic fibrosis
Year: 2021


Development of antibiotic-resistance in P. aeruginosa obtained from bronchiectasis patients: a multicenter prospective observational study
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018



The prevalence and diversity of fungi in respiratory samples of cystic fibrosis patients – a Dutch, nationwide, prospective, multicentre study
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018



Pneumothorax in cystic fibrosis. Case-control study
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010

Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study
Source: Virtual Congress 2021 – Imaging in COVID-19
Year: 2021